UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054119
Receipt number R000060702
Scientific Title Predicting neoadjuvant chemotherapy response of muscle-invasive bladder cancer using patient-derived zebrafish xenograft model: multi-institutional prospective study
Date of disclosure of the study information 2024/05/01
Last modified on 2024/04/11 13:36:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Predicting neoadjuvant chemotherapy response of muscle-invasive bladder cancer using patient-derived zebrafish xenograft model: multi-institutional prospective study

Acronym

Bladder cancer patient-derived zebrafish xenograft model

Scientific Title

Predicting neoadjuvant chemotherapy response of muscle-invasive bladder cancer using patient-derived zebrafish xenograft model: multi-institutional prospective study

Scientific Title:Acronym

Bladder cancer patient-derived zebrafish xenograft model

Region

Japan


Condition

Condition

Muscle-invasive bladder cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

Aim of this study is to evaluate response to platinum-based neoadjuvant chemotherapy (NAC) of muscle-invasive bladder cancer (MIBC) by trans-urethral resected bladder specimens transplanted zebrafish xenograft model and compared with pathological and histological diagnosis of radical cystectomy specimens after NAC. And near future we will apply zPDX system to clinical field for precision medicine before treating MIBC with platinum-based neoadjuvant chemotherapy.

Basic objectives2

Others

Basic objectives -Others

Gene expression/mutation analysis of bladder cancer tissue collected transurethrally and residual bladder cancer tissue in radical cystectomy specimens and comparative study of anticancer drug reactivity were conducted to find targets for platinum-based chemotherapy resistant cancer cells.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Bladder cancer tissue collected transurethrally before NAC from a patient scheduled to undergo radical cystectomy after neoadjuvant chemotherapy (NAC) with a platinum-based anticancer drug for muscle-invasive bladder cancer. Transplant into zebrafish and evaluate the effectiveness of platinum-based anticancer drugs. The results will be compared with the pathological evaluation of the total cystectomy specimen after NAC, and the concordance rate will be the primary endpoint.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. New case of muscle-invasive bladder cancer
2. Tumors of sufficient amount of transurethral resection
3. Patients who receive neoadjuvant platinum-based chemotherapy
4. Patients who receive radical cystectomy
5. Patients with available clinical and pathological information
6. Patients who consented.

Key exclusion criteria

Patients who are not appropriate to enter the clinical study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name TAKAHIRO
Middle name
Last name INOUE

Organization

Mie University Graduate School of Medicine

Division name

Nephro-Urologic Surgery and Andrology

Zip code

514-8507

Address

2-174 Edobashi Tsu Mie

TEL

0592315026

Email

tinoue28@med.mie-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Sugino

Organization

Mie University Graduate School of Medicine

Division name

Nephro-Urologic Surgery and Andrology

Zip code

514-8507

Address

2-174 Edobasih Tsu Mie

TEL

0592315026

Homepage URL


Email

tinoue28@med.mie-u.ac.jp


Sponsor or person

Institute

Mie University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Clinical Research Ethics Review Committee of Mie University Hospital

Address

2-174 Edobasih Tsu Mie

Tel

059-231-5045

Email

kk-sien@med.mie-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 04 Month 11 Day

Date of IRB


Anticipated trial start date

2024 Year 05 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patient information
Bladder cancer pathological information
Zebrafish xenograft successful rate
others


Management information

Registered date

2024 Year 04 Month 11 Day

Last modified on

2024 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060702